| Molecular Weight | 277.28 g/mol |
|---|---|
| Molecular Formula | C12H15N5O3 |
| XLogP3 | -0.8 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 2 |
| Exact Mass | 277.11748936 g/mol |
| Monoisotopic Mass | 277.11748936 g/mol |
| Topological Polar Surface Area | 126 A^2 |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 480 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 3 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 4 | |
|---|---|
| Drug Name | Baraclude |
| PubMed Health | Entecavir (By mouth) |
| Drug Classes | Antiviral |
| Drug Label | BARACLUDE is the tradename for entecavir, a guanosine nucleoside analogue with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,... |
| Active Ingredient | Entecavir |
| Dosage Form | Tablet; Solution |
| Route | Oral |
| Strength | 0.5mg; 0.05mg/ml; 1mg |
| Market Status | Prescription |
| Company | Bristol Myers Squibb |
| 2 of 4 | |
|---|---|
| Drug Name | Entecavir |
| PubMed Health | Entecavir (By mouth) |
| Drug Classes | Antiviral |
| Drug Label | BARACLUDE is the tradename for entecavir, a guanosine nucleoside analogue with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,... |
| Active Ingredient | Entecavir |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 0.5mg; 1mg |
| Market Status | Prescription |
| Company | Teva Pharms Usa |
| 3 of 4 | |
|---|---|
| Drug Name | Baraclude |
| PubMed Health | Entecavir (By mouth) |
| Drug Classes | Antiviral |
| Drug Label | BARACLUDE is the tradename for entecavir, a guanosine nucleoside analogue with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,... |
| Active Ingredient | Entecavir |
| Dosage Form | Tablet; Solution |
| Route | Oral |
| Strength | 0.5mg; 0.05mg/ml; 1mg |
| Market Status | Prescription |
| Company | Bristol Myers Squibb |
| 4 of 4 | |
|---|---|
| Drug Name | Entecavir |
| PubMed Health | Entecavir (By mouth) |
| Drug Classes | Antiviral |
| Drug Label | BARACLUDE is the tradename for entecavir, a guanosine nucleoside analogue with selective activity against HBV. The chemical name for entecavir is 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one,... |
| Active Ingredient | Entecavir |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 0.5mg; 1mg |
| Market Status | Prescription |
| Company | Teva Pharms Usa |
